STOCK TITAN
  1. Home
  2. News
  3. ENFN

Enfusion, Inc. - $ENFN STOCK NEWS

Welcome to our dedicated page for Enfusion news (Ticker: $ENFN), a resource for investors and traders seeking the latest updates and insights on Enfusion stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Enfusion's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Enfusion's position in the market.

News
Enfusion Elevates Valeria Gutowski to Chief Accounting Officer
Rhea-AI Summary
Enfusion, Inc. promotes Valeria Gutowski to Chief Accounting Officer, effective January 15, 2024. Ms. Gutowski will oversee financial reporting, SOX 404 compliance, tax, and accounting practices alignment with business strategies. She previously served as Enfusion's Controller and held positions at R.R. Donnelly. Valeria holds a Master of Science in Accounting from the University of Notre Dame and a Bachelor of Science in Finance from Brigham Young University.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
none
-
News
Enfusion Announces Appointment of Chief Operating Officer
Rhea-AI Summary
Enfusion, Inc. (NYSE: ENFN) appoints Neal Pawar, a financial services and technology leader with extensive experience at AQR Capital Management, D.E. Shaw, Deutsche Bank, and UBS Wealth Management, as its Chief Operating Officer. Pawar will focus on driving innovation and collaboration to optimize Enfusion's business operations and scale technology and infrastructure, ultimately enhancing the client experience.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.8%
Tags
management
-
News
Enfusion Announces Third Quarter 2023 Results
Rhea-AI Summary
Enfusion, Inc. (NYSE: ENFN) has released its third quarter 2023 financial results and will host an earnings conference call on November 7, 2023, at 8:30 am ET.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.86%
Tags
earnings
News
ConnexPay more than doubles client base since $110 million investment
Rhea-AI Summary
ConnexPay, the B2B payments company, has achieved significant growth following a $110 million investment. The company has doubled its customer base and expanded internationally, adding British Pounds and Euros as currencies. Leadership appointments have been made to drive global expansion. ConnexPay's annual revenue is forecast to grow 70% YoY. The company has also invested in its product offering, including push-to-card payouts and virtual card issuing. ConnexPay has received recognition for its growth and innovation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.18%
Tags
none
-
News
FTV Capital Named to Inc.’s Founder-Friendly Investors List for Third Consecutive Year
Rhea-AI Summary
FTV Capital has been included on Inc.'s annual Founder-Friendly Investors list for the third consecutive year. The list recognizes 218 firms that have a strong track record of success in supporting entrepreneurs. FTV has generated over $6.5 billion in realizations and deployed $5 billion into nearly 140 portfolio companies since its founding in 1998. The firm recently secured a minority investment from Blackstone GP Stakes and announced two investments in the financial services sector.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.84%
Tags
none
-
News
Enfusion Announces Date of Third Quarter 2023 Results
Rhea-AI Summary
Enfusion, Inc. to release its Q3 2023 financial results on November 7, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.34%
Tags
earnings
News
Enfusion Launches Portfolio Workbench, Empowering Portfolio Managers to Seamlessly Rebalance Multi-Asset Portfolios
Rhea-AI Summary
Enfusion announces the release of Portfolio Workbench, a new platform functionality that allows portfolio managers to manage and adjust their portfolios using an intuitive user interface. The tool integrates compliance checks and streamlines the entire workflow into a single interface.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.1%
Tags
none
-
News
RethinkFirst Appoints Lorelei Lenzen Skillman as Chief Marketing Officer
Rhea-AI Summary
RethinkFirst appoints Lorelei Lenzen Skillman as new chief marketing officer, aiming to deepen customer relationships and extend global reach.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.71%
Tags
management
-
News
Enfusion Announces Closing of New $100 Million Credit Facility
Rhea-AI Summary
Enfusion, Inc. entered into a new $100 million revolving credit facility, enhancing flexibility of balance sheet and providing a cost-effective source of capital for growth and potential acquisitions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.6%
Tags
none
News
Enfusion Announces Second Quarter 2023 Results
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.7%
Tags
earnings
Stock ENFN logo
Enfusion, Inc.

NYSE:ENFN

ENFN Rankings

#2572 Ranked by Market Cap
#4409 Ranked by Stock Gains
N/A Ranked by Dividends

ENFN Stock Data

866.72M
39.60M
8.53%
95.62%
2.51%
Software Publishers
Information
Link
United States of America
CHICAGO

About ENFN

enfusion is the leading provider of a cloud-based portfolio management and risk system. headquartered in chicago, illinois, with a branch office in new york, new york, and wholly-owned subsidiaries in london and hong kong, enfusion is a software company that focuses on delivering innovative solutions for clients in the financial services industry. our clients across the globe rely on our innovative real-time performance, risk calculations and accounting for some of the most sophisticated financial products. enfusion is undergoing exceptional growth and currently serves some of the world's largest and respected hedge funds with over 90 billion dollars of assets under management.